p53 mediates the cellular responses to cis-trimethoxystilbene in breast cancer cell lines

Julia Mirian Paulino1, Natália Dos Santos Gonçalves1, Heber Eduardo Andrada1

  • 1Laboratory of Genetics and Molecular Biology, University of Franca, Franca, SP, Brazil.

Natural Product Research
|October 7, 2025
PubMed

Insights

The compound cis-trimethoxystilbene (cis-TMS) effectively inhibits chemoresistant breast cancer cell growth and induces apoptosis. Its efficacy is dependent on the p53 tumor suppressor protein, suggesting a targeted therapy approach.

Area of Science:

  • * Molecular Biology
  • * Cancer Research
  • * Pharmacology

Background:

  • * Chemotherapy resistance in breast cancer presents a significant clinical challenge.
  • * The tumor suppressor protein p53 plays a critical role in cellular responses to DNA damage and stress.
  • * Novel therapeutic agents targeting cancer-specific pathways are needed.

Purpose of the Study:

  • * To investigate the anti-cancer effects of cis-trimethoxystilbene (cis-TMS) on chemoresistant breast cancer cells.
  • * To elucidate the role of the p53 protein in mediating cis-TMS-induced cellular responses.
  • * To explore cis-TMS as a potential targeted therapy for breast cancer.

Main Methods:

  • * Cell viability assays were performed on MDA-MB-231 breast cancer cells treated with cis-TMS.
  • * Apoptosis rates were quantified using flow cytometry.
  • * p53 gene silencing was employed in MCF-10A and MCF-7 cell lines to assess p53 dependency.
  • * Protein interaction studies were conducted to evaluate cis-TMS binding with p53.

Main Results:

  • * cis-TMS significantly inhibited MDA-MB-231 cell growth, reducing viability by ~75% at 2.5 µM.
  • * cis-TMS treatment increased apoptosis rates in cancer cells by nearly 20%.
  • * cis-TMS-induced apoptosis and cell cycle arrest were found to be p53-dependent.
  • * cis-TMS did not alter p53 conformation at low concentrations but may affect its activity at higher doses.

Conclusions:

  • * cis-TMS demonstrates potent anti-cancer activity against chemoresistant breast cancer cells.
  • * The therapeutic efficacy of cis-TMS is critically dependent on functional p53.
  • * cis-TMS selectively targets cancer cells with functional p53, indicating potential for targeted therapy.
  • * Further research is required to optimize cis-TMS therapeutic strategies, considering p53 reliance and potential genomic instability risks.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K